{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T21:28:36Z","timestamp":1792186116124,"version":"4.4.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009660","name":"London School of Hygiene and Tropical Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009660","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002141","name":"Public Health England","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","valueinhealthjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.jval.2020.07.011","type":"journal-article","created":{"date-parts":[[2020,11,14]],"date-time":"2020-11-14T08:17:10Z","timestamp":1605341830000},"page":"41-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Integrating Alternative Social Value Judgments Into Cost-Effectiveness Analysis of Vaccines: An Application to Varicella-Zoster Virus Vaccination"],"prefix":"10.1016","volume":"24","author":[{"given":"Jeroen","family":"Luyten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert Jan","family":"van Hoek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jval.2020.07.011_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.vaccine.2014.09.023","article-title":"Comparison of NITAG policies and working processes in selected developed countries","volume":"33","author":"Ricciardi","year":"2015","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.jval.2020.07.011_bib2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1017\/S0266462315000306","article-title":"How to introduce more (or better) ethical arguments in HTA?","volume":"31","author":"Schokkaert","year":"2015","journal-title":"Int J Technol Assess Health Care"},{"issue":"1","key":"10.1016\/j.jval.2020.07.011_bib3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0167-6296(91)90015-F","article-title":"QALYs and the equity-efficiency trade-off","volume":"10","author":"Wagstaff","year":"1991","journal-title":"J\u00a0Health Econ"},{"issue":"3","key":"10.1016\/j.jval.2020.07.011_bib4","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0167-6296(88)90030-6","article-title":"A\u00a0QALY is a QALY\u2014or is it?","volume":"7","author":"Weinstein","year":"1988","journal-title":"J\u00a0Health Econ"},{"issue":"5","key":"10.1016\/j.jval.2020.07.011_bib5","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.socscimed.2009.06.026","article-title":"Maximisation in extra-welfarism: A critique of the current position in health economics","volume":"69","author":"Coast","year":"2009","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.jval.2020.07.011_bib6","series-title":"Valuing Health","author":"Hausman","year":"2015"},{"issue":"Suppl 1","key":"10.1016\/j.jval.2020.07.011_bib7","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1111\/j.1524-4733.2009.00516.x","article-title":"QALYs: some challenges","volume":"12","author":"Nord","year":"2009","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2020.07.011_bib8","series-title":"Distributional Cost-Effectiveness Analysis: Quantifying Health Equity Impacts and Trade-Offs","author":"Cookson","year":"2020"},{"issue":"2","key":"10.1016\/j.jval.2020.07.011_bib9","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/hec.924","article-title":"QALY maximisation and people's preferences: a methodological review of the literature","volume":"14","author":"Dolan","year":"2005","journal-title":"Health Econ"},{"issue":"2","key":"10.1016\/j.jval.2020.07.011_bib10","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jval.2014.12.007","article-title":"Public preferences for prioritizing preventive and curative health care interventions: a discrete choice experiment","volume":"18","author":"Luyten","year":"2015","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2020.07.011_bib11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.socscimed.2015.10.005","article-title":"Attributes and weights in health care priority setting: A systematic review of what counts and to what extent","volume":"146","author":"Gu","year":"2015","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.jval.2020.07.011_bib12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.socscimed.2019.03.025","article-title":"Quantifying the public\u2019s view on social value judgments in vaccine decision-making: A discrete choice experiment","volume":"228","author":"Luyten","year":"2019","journal-title":"Soc Sci Med"},{"issue":"2-3","key":"10.1016\/j.jval.2020.07.011_bib13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.healthpol.2009.08.005","article-title":"Severity of illness and priority setting in healthcare: a review of the literature","volume":"93","author":"Shah","year":"2009","journal-title":"Health Policy"},{"issue":"Suppl 1","key":"10.1016\/j.jval.2020.07.011_bib14","doi-asserted-by":"crossref","first-page":"A50","DOI":"10.1016\/j.vaccine.2016.09.072","article-title":"Planning and priority setting for vaccine development and immunization","volume":"35","author":"Phelps","year":"2017","journal-title":"Vaccine"},{"issue":"34","key":"10.1016\/j.jval.2020.07.011_bib15","doi-asserted-by":"crossref","first-page":"12313","DOI":"10.1073\/pnas.1400475111","article-title":"Valuing vaccination","volume":"111","author":"Barnighausen","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1016\/j.jval.2020.07.011_bib16","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.vaccine.2011.12.053","article-title":"Evidence-based decision making for vaccines: the need for an ethical foundation","volume":"30","author":"Field","year":"2012","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.jval.2020.07.011_bib17","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s40273-014-0212-4","article-title":"Cost-value analysis of health interventions: introduction and update on methods and preference data","volume":"33","author":"Nord","year":"2015","journal-title":"Pharmacoeconomics"},{"issue":"2","key":"10.1016\/j.jval.2020.07.011_bib18","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jval.2016.11.027","article-title":"Using cost-effectiveness analysis to address health equity concerns","volume":"20","author":"Cookson","year":"2017","journal-title":"Value Health"},{"issue":"1","key":"10.1016\/j.jval.2020.07.011_bib19","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/0272989X15583266","article-title":"Distributional cost-effectiveness analysis: a tutorial","volume":"36","author":"Asaria","year":"2016","journal-title":"Med Decis Making"},{"issue":"2","key":"10.1016\/j.jval.2020.07.011_bib20","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jhealeco.2011.01.003","article-title":"Deriving distributional weights for QALYs through discrete choice experiments","volume":"30","author":"Lancsar","year":"2011","journal-title":"J\u00a0Health Econ"},{"issue":"4","key":"10.1016\/j.jval.2020.07.011_bib21","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1467-8519.2005.00452.x","article-title":"Public communication, risk perception, and the viability of preventive vaccination against communicable diseases","volume":"19","author":"May","year":"2005","journal-title":"Bioethics"},{"issue":"1","key":"10.1016\/j.jval.2020.07.011_bib22","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1542\/peds.2008-0987","article-title":"Protecting public trust in immunization","volume":"122","author":"Cooper","year":"2008","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.jval.2020.07.011_bib23","doi-asserted-by":"crossref","first-page":"e827","DOI":"10.1542\/peds.2005-1556","article-title":"Intussusception after administration of the rhesus tetravalent rotavirus vaccine (Rotashield): the search for a pathogenic mechanism","volume":"117","author":"Lynch","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.jval.2020.07.011_bib24","series-title":"History of Vaccine Development","first-page":"73","article-title":"The history of pertussis vaccination: from whole-cell to subunit vaccines","author":"Granstr\u00f6m","year":"2011"},{"issue":"10215","key":"10.1016\/j.jval.2020.07.011_bib25","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/S0140-6736(19)32525-5","article-title":"Vaccine-attributable severe dengue in the Philippines","volume":"394","author":"Wilder-Smith","year":"2019","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.jval.2020.07.011_bib26","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.vaccine.2011.11.026","article-title":"The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom","volume":"30","author":"van Hoek","year":"2012","journal-title":"Vaccine"},{"issue":"52","key":"10.1016\/j.jval.2020.07.011_bib27","doi-asserted-by":"crossref","first-page":"7175","DOI":"10.1016\/j.vaccine.2014.10.015","article-title":"Varicella-zoster virus vaccination under the exogenous boosting hypothesis: two ethical perspectives","volume":"32","author":"Luyten","year":"2014","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.jval.2020.07.011_bib28","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1017\/S0950268811002640","article-title":"The health and economic burden of chickenpox and herpes zoster in Belgium","volume":"140","author":"Bilcke","year":"2012","journal-title":"Epidemiol Infect"},{"issue":"6","key":"10.1016\/j.jval.2020.07.011_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066485","article-title":"Herpes zoster risk reduction through exposure to chickenpox patients: a systematic multidisciplinary review","volume":"8","author":"Ogunjimi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jval.2020.07.011_bib30","doi-asserted-by":"crossref","DOI":"10.1080\/15265161.2020.1795528","article-title":"Pox parties for grannies? chickenpox, exogenous boosting, and harmful injustices","author":"Malm","year":"2020","journal-title":"Amer J Bioethics"},{"key":"10.1016\/j.jval.2020.07.011_bib31","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1080\/15265161.2020.1795533","article-title":"Aggregate wellbeing as foundation to discourage childhood chickenpox vaccination","volume":"20","author":"Luyten","year":"2020","journal-title":"Am J Bioeth"},{"issue":"3","key":"10.1016\/j.jval.2020.07.011_bib32","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1371\/journal.pmed.0050074","article-title":"Social contacts and mixing patterns relevant to the spread of infectious diseases","volume":"5","author":"Mossong","year":"2008","journal-title":"PLoS Med"},{"issue":"8","key":"10.1016\/j.jval.2020.07.011_bib33","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s00431-002-0981-1","article-title":"Herpes zoster by reactivated vaccine\u00a0varicella zoster virus in a healthy child","volume":"161","author":"Uebe","year":"2002","journal-title":"Eur J Pediatr"},{"issue":"1","key":"10.1016\/j.jval.2020.07.011_bib34","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12955-019-1147-4","article-title":"Usability of daily SF36 questionnaires to capture the QALD variation experienced after vaccination with AS03A-adjuvanted monovalent influenza A (H5N1) vaccine in a safety and tolerability study","volume":"17","author":"Standaert","year":"2019","journal-title":"Health Qual Life Outcomes"},{"issue":"11","key":"10.1016\/j.jval.2020.07.011_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111807","article-title":"The burden of disease and health care use among pertussis cases in school aged children and adults in England and Wales: a patient survey","volume":"9","author":"van Hoek","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jval.2020.07.011_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017030","article-title":"The impact of pandemic influenza H1N1 on health-related quality of life: a prospective population-based study","volume":"6","author":"van Hoek","year":"2011","journal-title":"PLoS One"},{"issue":"18","key":"10.1016\/j.jval.2020.07.011_bib37","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1016\/j.vaccine.2019.03.041","article-title":"Assessing vaccine hesitancy in the UK population using a generalized vaccine hesitancy survey instrument","volume":"37","author":"Luyten","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.jval.2020.07.011_bib38","doi-asserted-by":"crossref","first-page":"l6987","DOI":"10.1136\/bmj.l6987","article-title":"Risk of herpes zoster after exposure to varicella to explore the exogenous boosting hypothesis: self controlled case series study using UK electronic healthcare data","volume":"368","author":"Forbes","year":"2020","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.jval.2020.07.011_bib39","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/cid\/ciy1099","article-title":"systematic review and meta-analysis of chickenpox vaccination and risk of herpes zoster: a quantitative view on the \u201cexogenous\u00a0boosting hypothesis","volume":"69","author":"Harder","year":"2018","journal-title":"Clinical Infectious Dis"},{"issue":"6","key":"10.1016\/j.jval.2020.07.011_bib40","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1093\/cid\/ciz305","article-title":"The impact of varicella vaccination on the incidence of varicella and herpes zoster in the United States: updated evidence from observational databases, 1991\u20132016","volume":"70","author":"Wolfson","year":"2019","journal-title":"Clinical Infectious Dis"},{"issue":"2","key":"10.1016\/j.jval.2020.07.011_bib41","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1377\/hlthaff.2015.1088","article-title":"The social value of vaccination programs: beyond cost-effectiveness","volume":"35","author":"Luyten","year":"2016","journal-title":"Health Aff (Millwood)"},{"issue":"1","key":"10.1016\/j.jval.2020.07.011_bib42","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/(SICI)1099-1050(200001)9:1<57::AID-HEC484>3.0.CO;2-N","article-title":"QALYs and ageism: philosophical theories and age weighting","volume":"9","author":"Tsuchiya","year":"2000","journal-title":"Health Econ"},{"issue":"11","key":"10.1016\/j.jval.2020.07.011_bib43","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s40264-015-0350-4","article-title":"Comparative safety of vaccine adjuvants: a summary of current evidence and future needs","volume":"38","author":"Petrovsky","year":"2015","journal-title":"Drug Saf"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301520343941?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301520343941?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T01:22:22Z","timestamp":1761096142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301520343941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1098301520343941"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2020.07.011","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrating Alternative Social Value Judgments Into Cost-Effectiveness Analysis of Vaccines: An Application to Varicella-Zoster Virus Vaccination","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2020.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 ISPOR-The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}